ROTUOC
Regents of the University of California Portfolio holdings
AUM
$515M
This Quarter Return
+8.6%
1 Year Return
+25.31%
3 Year Return
+76.79%
5 Year Return
+62.93%
10 Year Return
+567.68%
AUM
$156M
AUM Growth
+$156M
(-15%)
Cap. Flow
-$39.6M
Cap. Flow
% of AUM
-25.32%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
6
Top Buys
| 1 |
Surrozen, Inc. Warrant
SRZNW
|
$1.57M |
Top Sells
| 1 |
Blue Owl Capital
OBDC
|
$34.4M |
| 2 |
Intellia Therapeutics
NTLA
|
$2.63M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$2.33M |
| 4 |
Sana Biotechnology
SANA
|
$853K |
| 5 |
Erasca
ERAS
|
$558K |
Sector Composition
| 1 | Financials | 99% |
| 2 | Communication Services | 0% |
| 3 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Blue Owl Capital
OWL
$12.1B
| $155M | 99% |
7,988,767
| – | – |
|
|
2
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $1.57M | 1% |
+216,540
| New | +$1.57M |
|
|
3
Berkshire Hathaway Class B
BRK.B
$1.09T
| – | – |
-5,723
| Closed | -$2.33M |
|
|
4
Erasca
ERAS
$445M
| – | – |
-236,236
| Closed | -$558K |
|
|
5
Intellia Therapeutics
NTLA
$1.22B
| – | – |
-117,315
| Closed | -$2.63M |
|
|
6
Blue Owl Capital
OBDC
$7.33B
| – | – |
-2,237,060
| Closed | -$34.4M |
|
|
7
Sana Biotechnology
SANA
$777M
| – | – |
-156,254
| Closed | -$853K |
|
8
Verizon
VZ
$186B
| – | – |
-9,927
| Closed | -$409K |
|